About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 976383, 8 pages
http://dx.doi.org/10.1155/2013/976383
Research Article

Characterization of CD8+ T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)

1Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology and Dendritic Cell Bank, Vrije Universiteit Brussel, 1090 Brussels, Belgium
2Department of Medical Oncology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium

Received 4 June 2012; Accepted 21 July 2012

Academic Editor: Julie Curtsinger

Copyright © 2013 Daphné Benteyn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. van Nuffel, D. Benteyn, S. Wilgenhof, et al., “Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients,” Molecular Therapy, vol. 20, no. 5, pp. 1063–1074, 2012. View at Publisher · View at Google Scholar
  2. V. F. van Tendeloo, A. van de Veldea, A. van Driesschea et al., “Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 31, pp. 13824–13829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. van Nuffel, D. Benteyn, S. Wilgenhof, et al., “Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient,” Cancer Immunology, Immunotherapy, vol. 61, no. 7, pp. 1033–1043, 2012. View at Publisher · View at Google Scholar
  4. A. Bonehill, A. M. T. van Nuffel, J. Corthals et al., “Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients,” Clinical Cancer Research, vol. 15, no. 10, pp. 3366–3375, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. E. P. M. Tjin, D. Konijnenberg, G. Krebbers et al., “T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy,” Clinical Cancer Research, vol. 17, no. 17, pp. 5736–5747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. I. Suso, S. Dueland, A. M. Rasmussen et al., “HTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes,” Cancer Immunology, Immunotherapy, vol. 60, no. 6, pp. 809–818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. I. J. M. de Vries, M. R. Bernsen, W. J. Lesterhuis et al., “Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome,” Journal of Clinical Oncology, vol. 23, no. 24, pp. 5779–5787, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. van Nuffel, S. Tuyaerts, D. Benteyn, et al., “Epitope and HLA-type independent monitoring of antigen-specific T-cells after treatment with dendritic cells presenting full-length tumor antigens,” Journal of Immunological Methods, vol. 377, no. 1-2, pp. 23–36, 2012. View at Publisher · View at Google Scholar
  9. S. van Lint, C. Goyvaerts, S. Maenhout et al., “Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy,” Cancer Research, vol. 72, no. 7, pp. 1661–1671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Wilgenhof, A. M. T. van Nuffel, J. Corthals et al., “Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma,” Journal of Immunotherapy, vol. 34, no. 5, pp. 448–456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. van Nuffel, J. Corthals, B. Neyns, C. Heirman, K. Thielemans, and A. Bonehill, “Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation,” Methods in Molecular Biology, vol. 629, pp. 405–452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bonehill, A. M. T. van Nuffel, J. Corthals et al., “Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients,” Clinical Cancer Research, vol. 15, no. 10, pp. 3366–3375, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. F. Brunsvig, S. Aamdal, M. K. Gjertsen et al., “Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer,” Cancer Immunology, Immunotherapy, vol. 55, no. 12, pp. 1553–1564, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. E. Hunger, K. Kernland Lang, C. J. Markowski et al., “Vaccination of patients with cutaneous melanoma with telomerase-specific peptides,” Cancer Immunology, Immunotherapy, vol. 60, no. 11, pp. 1553–1564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. W. J. Lesterhuis, I. J. M. de Vries, D. H. Schuurhuis et al., “Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests,” Annals of Oncology, vol. 17, no. 6, pp. 974–980, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. W. J. Lesterhuis, G. Schreibelt, N. M. Scharenborg et al., “Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used,” Cancer Immunology, Immunotherapy, vol. 60, no. 2, pp. 249–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Bonehill, S. Tuyaerts, A. M. T. van Nuffel et al., “Enhancing the t-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA,” Molecular Therapy, vol. 16, no. 6, pp. 1170–1180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Mullins, S. L. Sheasley, R. M. Ream, T. N. J. Bullock, Y. X. Fu, and V. H. C.-P. Engelhard, “Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control,” Journal of Experimental Medicine, vol. 198, no. 7, pp. 1023–1034, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. R. Ferguson and V. H. C.-P. Engelhard, “CD8 T cells activated in distinct lymphoid organs differentially express adhesion proteins and coexpress multiple chemokine receptors,” Journal of Immunology, vol. 184, no. 8, pp. 4079–4086, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Ferguson, L. A. Nichols, A. L. Zarling et al., “Strategies and challenges in eliciting immunity to melanoma,” Immunological Reviews, vol. 222, no. 1, pp. 28–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. R. Hadrup and T. N. Schumacher, “MHC-based detection of antigen-specific CD8+ T cell responses,” Cancer Immunology, Immunotherapy, vol. 59, no. 9, pp. 1425–1433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. R. S. Andersen, P. Kvistborg, T. M. Frøsig, et al., “Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers,” Nature Protocols, vol. 7, pp. 891–902, 2012. View at Publisher · View at Google Scholar
  23. J. H. Velthuis, W. W. Unger, J. R. F. Abreu et al., “Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers,” Diabetes, vol. 59, no. 7, pp. 1721–1730, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. S. van der Bruggen, N. Vigneron, and B. van den Eynde, “Peptide Database,” http://cancerimmunity.org/peptide/.